DAPT After PCI: Sex-Specific Strategies Unveiled
Bartosz Hudzik, Associate Professor in Cardiology at Silesian Center for Heart Disease, shared a post on X։
“DAPT after PCI: Risks change over time. Meta-analysis finds sex-specific benefits.
Aspirin discontinuation may represent the optimal strategy for women, while P2Y12i switch to clopidogrel may be most effective for men.”
Read the full article here.
Article: Sex differences in dual antiplatelet therapy de-escalation strategies after percutaneous coronary intervention: a network meta-analysis
Authors: Giovanni Occhipinti, Claudio Laudani, Mattia Galli, Luis Ortega-Paz, Vijay Kunadian, Guiomar Mendieta, Riccardo Rinaldi, Felicita Andreotti, Roxana Mehran, Teresa López-Sobrino, Davide Capodanno, Dominick J Angiolillo, Manel Sabaté Tenas, Salvatore Brugaletta
Stay updated on all science in the field of hematology with Hemostasis Today.
-
Jan 7, 2026, 08:50Fahad Khaliq on When is Ticagrelor Preferred Over Other Antiplatelets
-
Jan 7, 2026, 06:41Zain Khalpey on AI Driven Risk Prediction for Optimization of Anticoagulation in LVAD
-
Jan 7, 2026, 05:47Michael Makris: The Wakley Prize Essay Published in Today’s Lancet is an Excellent Read
-
Jan 7, 2026, 05:36Pierre F Sabouret Shares A Study on the Risk of Cardiovascular Death in SIDs
-
Jan 7, 2026, 05:15Glaivy Batsuli Reflects on ASH25
-
Jan 7, 2026, 05:04Heghine Khachatryan on VWD: A Landmark in the History of Hematology
-
Jan 6, 2026, 13:39JAMA Neurology: No Added Benefit of Dual Therapy After Ischemic Stroke in Case of AFib
-
Jan 6, 2026, 10:10This is Fantastic: Shirley D’Sa on Transfusion-Free Christmas Milestone for 𝛃-Thalassaemia Patient at UCLH
-
Jan 6, 2026, 09:53Hamideh Yadegari: Coagulation–Inflammation Crosstalk: Mechanisms, Pathways, and Clinical Implications